What was Quest Pharmatech’s price range in the past 12 months?
Quest Pharmatech lowest stock price was C$0.02 and its highest was C$0.05 in the past 12 months.
What is Quest Pharmatech’s market cap?
Quest Pharmatech’s market cap is C$3.38M.
When is Quest Pharmatech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Quest Pharmatech’s earnings last quarter?
Quest Pharmatech released its earnings results on Sep 25, 2026. The company reported C$0.002 earnings per share for the quarter.
Is Quest Pharmatech overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Quest Pharmatech pay dividends?
Quest Pharmatech does not currently pay dividends.
What is Quest Pharmatech’s EPS estimate?
Quest Pharmatech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quest Pharmatech have?
Quest Pharmatech has 169,129,240 shares outstanding.
What happened to Quest Pharmatech’s price movement after its last earnings report?
Quest Pharmatech reported an EPS of C$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Quest Pharmatech?
Currently, no hedge funds are holding shares in TSE:QPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quest Pharmatech
Quest PharmaTech Inc is a Canadian based pharmaceutical company. The company through its subsidiary is developing antibody-based immunotherapeutic products for cancer. In addition, it owns the photodynamic therapy technology for oncology and dermatology applications.